Comprehensive Analysis of the Immune and Prognostic Implication of MMP14 in Lung Cancer.

More and more studies have indicated an association between immune infiltration in lung cancer and clinical outcomes. Matrix metalloproteinase 14 (MMP14) has been reported to be dysregulated in many types of tumors and involved in the development and progression of tumors. However, its contribution to cancer immunity was rarely reported. In the study, we found that MMP14 expression was distinctly upregulated in lung cancer specimens compared with nontumor lung specimens. High MMP14 expression predicted a poor prognosis of lung squamous cell carcinoma (LUSC) patients. Increased MMP14 expressions were observed to be positively related to high immune infiltration levels in most of the immune cells. A pathway enrichment analysis of 32 MMP14-associated immunomodulators indicated the involvement of T cell receptor signaling pathway and Toll-like receptor signaling pathway. Based on MMP14-associated immunomodulators, we applied multivariate assays to construct multiple-gene risk prediction signatures. We observed that risk scores were independently associated with overall survival. These data highlighted that MMP14 was involved in tumor immunity, indicating that MMP14 could serve as a novel prognostic biomarker and therapeutic target for lung cancer. Our data suggest that the four genes identified in this study may serve as valuable biomarkers of lung cancer patient outcomes. Copyright © 2021 Chun-long Zheng et al.

Citation

Chun-Long Zheng, Qiang Lu, Nian Zhang, Peng-Yu Jing, Ji-Peng Zhang, Wu-Ping Wang, Gui-Zhen Li. Comprehensive Analysis of the Immune and Prognostic Implication of MMP14 in Lung Cancer. Disease markers. 2021;2021:5917506

Mesh Tags

Substances

PMID: 34868395

search → result